Log In
BCIQ
Print this Print this
 

557296

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionOxytocin antagonist
Molecular Target Oxytocin (OXT) (OT)
Mechanism of ActionOxytocin inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationPremature ejaculation
Indication DetailsTreat premature ejaculation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today